ImmunityBio Inc (IBRX)

[stock1ace1]

$5.95 Up 10% **24 Mill shares short roughly that need to cover big squeeze incoming !!

84 mill float / 29% short = 24 Million shares

[stock1ace1]

Short Squeeze Watch !

[stock1ace1]

IBRX $5.40 ** 29% short (24 Mill shares) of 83 mill float !

Golden cross
Macd pinch

[mick]

NK
NantKwest Inc
32.49
0.00 (0.00%)
Volume: -
Bid: 32.49
Ask: 32.70
NK Detailed Quote

[Happycoins]

Ibrx expect a big swing monday .
Up premarket down quick at the open then a recovery
around 10.15 always a drop at noon then upward to 3 then a drop around 3 15.
Got to love the day traders they are making me money so predictable.
Bought at 6.50 pershare up in shares and value because of the trade patterns.
Sell at market at open buy 15 mins later.
Vicious cycle and must be super observant .
Long term huge winner !!!
Also I like Jmia and Smmt

[mick]

IBRX
ImmunityBio Inc
4.00
0.16 (4.17%)
Volume: 743,791
Day Range: 3.87 - 4.085
Bid: 3.98
Ask: 4.05
Last Trade Time: 5:43:28 PM EDT
Total Trades: 5,353
IBRX Detailed Quote

[mick]

IBRX
ImmunityBio Inc
4.61
0.21 (4.77%)
Volume: 808,591
Day Range: 4.26 - 4.545
Bid: 4.37
Ask: 4.61
Last Trade Time: 7:28:50 PM EDT
Total Trades: 7,560
IBRX Detailed Quote

[mick]

ImmunityBio Inc (IBRX)
3.65 ? 0.31 (9.28%)
Volume: 2,784,724 @06/03/22 7:56:12 PM EDT
Bid Ask Day's Range
3.6 3.65 3.22 - 3.69
IBRX Detailed Quote

[123414]

[url][/https://www.urotoday.com/conference-highlights/2022-annual-meeting/aua-2022-bladder-caner/137101-aua-2022-final-clinical-results-of-pivotal-trial-of-il-15r-alpha-fc-superagonist-n-803-with-bcg-in-bcg-unresponsive-non-muscle-invasive-bladder-cancer-nmibc-cis-and-papillary-cohorts?mtm_campaign=Chamie_SocialAUA22_ID137101url][tag]Final Clinical Results of Pivotal Trial of IL-15R&[alpha]Fc Superagonist N-803 with BCG in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) CIS and Papillary Cohorts/tag]

[123414]

trade 19112 nsad 16;00;01 271,005 share buy

Big money moving in on the down low...

BULLISH

Expect analyst updates AFTER MORE LIKE 19112.

Bullish activity.

back to double digits soon .... JMO

[123414]

trade 19112 nsad 16;00;01 271,005 share buy

Big money moving in on the down low...

BULLISH

Expect analyst updates AFTER MORE LIKE 19112.

Bullish activity.

back to double digits soon .... JMO

[mick]

yes /\ IBRX
ImmunityBio Inc
3.705
-0.255 (-6.44%)
Volume: 598,424
Day Range: 3.655 - 3.91
Bid: 3.70
Ask: 3.71
Last Trade Time: 11:57:01 AM EDT
Total Trades: 4,967

[123414]

accumulation.

[mick]

ImmunityBio Inc (IBRX)
3.75 ? 0.01 (0.27%)
Volume: 1,533,996 @04/29/22 7:35:53 PM EDT
Bid Ask Day's Range
3.72 3.8 3.615 - 4.035
IBRX Detailed Quote

[IronPantz]

Shorts have been loosing billions and billions across a number of stocks in just the last few months. Ho Ho Ho. I'm grabbing up more too.

[Happycoins]

Huge sell off today .
Many drugs in phase 2 and 3.
Grabbed 2900 shares at 4.34 a gift.
Shorts are having a jolly good time but are blind folded at the moment.
They are all about to be stampeded by bulls soon.
90 % of shares are in strong hands.
Margin calls are going to kick in driving the pps up.
Any positive results from fda will cause a explosion in the pps.
Pharmaceutical stocks like ibrx are suicide to short with so many late stage drugs in the pipe line plus about 90% of the shares are tide up.
GLTA !!!
Last price 4.38 april 21.

[123414]

The comp hit 67% CR at 18/24months on one dose ph 1

FDA issued BTD AA Priority review from that data.

Then the first 12 patients were undertreated.

Now full dose data is becoming dominant in study
and in the NMIBC Nonresponse market.

[123414]

This recent article from UroToday (01 April) reveals that the 2 year CR rate for N-803 is around 36%:

"In Cohort A, complete response was noted in 59 of 83 (71%) at the primary endpoint designated 3- or 6-month time point. Impressively, more than half (52%) had durable response out to 2 years or beyond."

52% of 59 = 30 out of 83 patients = 36%

This jives with Immunity Bio's announcement of their results in February:

"Indeed, the benchmark of 30% durable response at 18 to 24 months for a clinically meaningful therapy “is likely too high and may not be realistically achievable,”3 according to recommendations published in the Journal of Clinical Oncology. This “realistically unachievable” endpoint of 30% durable response at 18 months has in fact now been achieved and exceeded with the combination of Anktiva and BCG in this trial reported today. "

According to the list at the bottom of the following article TLD1433 is one of 14 trials currently going on in this space.

[mick]

ImmunityBio Inc (IBRX)
6.05 ? 0.44 (7.84%)
Volume: 1,442,639 @04/01/22 7:58:13 PM EDT
Bid Ask Day's Range
6.05 6.5 5.51 - 5.935
IBRX Detailed Quote

[mick]

ImmunityBio Inc (IBRX)
6.01 ? -0.54 (-8.24%)
Volume: 970,886 @03/11/22 7:35:28 PM EST
Bid Ask Day's Range
6.05 6.22 6.0 - 6.66
IBRX Detailed Quote

[mick]

ImmunityBio Inc (IBRX)
5.72 ? 0.38 (7.12%)
Volume: 1,225,522 @02/04/22 5:58:42 PM EST
Bid Ask Day's Range
5.31 5.45 5.1616 - 5.51
IBRX Detailed Quote

[mick]

https://www.otcmarkets.com/stock/IBRX

[martind18]

Nice close on Friday. News is coming... just a matter of time.

[mick]

https://www.otcmarkets.com/stock/IBRX

[mick]

Baylor, TCH and ImmunityBio collaborate for COVID-19 vaccine for Africa

Nov 23, 2021

https://www.bcm.edu/news/baylor-tch-and-immunitybio-collaborate-for-covid-19-vaccine-for-africa

Second generation.

Happy Thanksgiving Mick!

[mick]

thank you happy thanksgiving 11-24-2021

[Phosphene]

Baylor, TCH and ImmunityBio collaborate for COVID-19 vaccine for Africa

Nov 23, 2021

https://www.bcm.edu/news/baylor-tch-and-immunitybio-collaborate-for-covid-19-vaccine-for-africa

Second generation.

Happy Thanksgiving Mick!

[mick]

ImmunityBio Inc (IBRX)
8.73 ? 0.1 (1.16%)
Volume: 837,388 @11/05/21 7:54:30 PM EDT
Bid Ask Day's Range
8.59 8.74 8.2802 - 8.94
IBRX Detailed Quote

[mick]

ImmunityBio Inc (IBRX)
8.83 ? -0.87 (-8.97%)
Volume: 1,078,463 @10/08/21 7:52:35 PM EDT
Bid Ask Day's Range
8.81 8.83 8.76 - 9.6545
IBRX Detailed Quote

[mick]

ImmunityBio Inc (IBRX)
10.12 ? 0.21 (2.12%)
Volume: 516,838 @09/22/21 5:59:48 PM EDT
Bid Ask Day's Range
10.12 10.14 9.88 - 10.17
IBRX Detailed Quote

[stlogic]

Big week coming for IBRX

[mick]

ImmunityBio Inc (IBRX)
11.25 ? -0.15 (-1.32%)
Volume: 393,234 @08/13/21 6:05:14 PM EDT
Bid Ask Day's Range
11.25 11.69 11.25 - 11.67
IBRX Detailed Quote

[retired early]

Yes you are correct. "ImmunityBios Novel Immunotherapy NANT Cancer Vaccine Currently Being Studied in Multiple Clinical Trials Is Awarded a U.S. Patent" :)

[martind18]

Every time good news comes out.... we drop.
I’m hoping some bad news comes to get this going again.

[mick]

ImmunityBio Inc (IBRX)
13.07 ? 0.44 (3.48%)
Volume: 617,228 @07/09/21 6:44:11 PM EDT
Bid Ask Day's Range
12.75 13.0 12.4 - 13.13
IBRX Detailed Quote

[martind18]

Man.... at this rate... we will be a penny stock soon!

[mick]

ImmunityBio Inc (IBRX)
16.2194 ? 0.4794 (3.05%)
Volume: 269,098 @05/26/21 12:17:30 PM EDT
Bid Ask Day's Range
16.18 16.22 15.57 - 16.22
IBRX Detailed Quote

[retired early]

Sure looks that way to me. :)

[retired early]

Perhaps we hit the bottom and up we go. :)

[mick]

[Tamtam]

I hope so

[martind18]

News coming.... soon.

[mick]

ImmunityBio Inc (IBRX)
17.41 ? 0.15 (0.87%)
Volume: 896,410 @04/16/21 7:55:08 PM EDT
Bid Ask Day's Range
13.0 225.0 16.15 - 17.38
IBRX Detailed Quote

[stlogic]

I'm like a crack addict bought more. Nothing would

make me happier than defeating cancer AND making money from it's death.

Kaiser is using Immune therapy now. Friend of mine is in therapy now has melanoma.
Nurse told him all cancer treatments going this way. HMO's
looking for cures I'm sure they loose money on long term treatments.

Another friends brother with stage 4 pancreatic cancer just got accepted to HOAG
for IBRX trial on my recommendation.

PSS alluded that politics played a role in stalling them.
I believe that Moderna is Fauci and Gates baby. Problem is the vaccine doesn't kill SARs

IF we kill SARS host to all variants what's the stock worth?
16 dollars? lol shorty ganna get crushed if South Africa approves
then Fauci will be forced to face reality. I'm not a fan of the exCIA chief on the
board but I see the politics required to play this game.

Hey whatever it takes. Fuck cancer

[sk8er]

Google dark pool trading. How the hell is this legal?

[sk8er]

Welp: looks like big pharma is trying to bankrupt this fine company. Every day the hedge funds cut this down, every day. They want to hedge against their losses when this becomes main stream or hit's the right news network. All of the treatment's that they have in the pipeline will become worthless when that happens. in one day. They are trying to get patents that treat the same affliction that this company is curing. These hedge funds are trying to lesson the blow to the bottom line when this happens. Hedging against losses. Treating and not curing people has become such a big business that you can see what is happening. Every day on the close monster short selling to go into the next day. These pharma companies have already counted the revenue that will never reach the coffers. Just look at 3-19 end of day trading. 2 million shares shorted and they made the bars look green. Every person in here should google "dark pool trading" to get an idea what is happening. Big pharma is so sweet that they take drugs that cost them .30 to produce then charge children parents thousands of dollars for a prescription. This is legal some how. I contact my representatives here in Alaska and told them I do not want our perm fund to have any part in this debauchery. Unless they go long. If this goes game stop then it will be halted, then the mother of all short squeezes will happen before your eyes I think. We need to take these hedge funds out permanently. Big pharma sucks.

[retired early]

11 late-stage natural killer and cell therapy candidates - that's worth investing in. :)

[vinmantoo]

The IBRX market cap is $6.5 billion, a big drop from the $13 billion or so it was at before. It may stabilize soon, say by $5 billion or even less. FATE is at $7.5 billion from close to the $13 billion is was at so it might have a bigger drop left than IBRX as FATE doesn't have a Covid-19 vaccine in the pipeline like IBRX does.

[Tamtam]

It looks like IBRX is in free fall

[Jgdusmc]

Right what is going on here